시장보고서
상품코드
1670157

생체 흡수 스텐트 시장 규모, 점유율, 성장 분석, 제품 유형별, 흡수율별, 용도별, 지역별 - 산업 예측(2025-2032년)

Bioabsorbable Stents Market Size, Share, and Growth Analysis, By Product Type, By Absorption Rate, By Application, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 194 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생체 흡수성 스텐트 시장 규모는 2023년 25억 6,000만 달러로 평가되었습니다. 2024년 27억 9,000만 달러에서 2032년에는 55억 1,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 8.9%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.

세계 생체 흡수성 스텐트 시장은 고령화와 심혈관 질환 유병률 증가로 인해 크게 성장할 것으로 예상됩니다. 관상동맥 질환 증가는 경피적 관상동맥 성형술(PCI) 시술 증가로 이어져 환자와 의료진 모두 생체 흡수성 스텐트의 채택을 확대하고 있습니다. 기술 발전과 최소 침습적 치료로의 전환은 시장 확대를 더욱 촉진하고 있습니다. 기술 혁신을 촉진하는 개발 이니셔티브와 유리한 규제는 생체 흡수성 스텐트 개발을 촉진하고 있습니다. 그러나 높은 시술 비용과 스텐트 시술에 따른 잠재적 위험과 같은 문제는 성장을 저해하는 요인으로 작용할 수 있습니다. 전반적으로 인구 통계학적 변화, 기술 발전, 정부 지원책이 시장의 미래 궤도를 형성하는 데 중요한 역할을 할 것으로 보입니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 사례 연구
  • 규제 상황

생체 흡수 스텐트 시장 규모 : 제품 유형별

  • 시장 개요
  • 폴리머 기반 생체 흡수 스텐트
  • 메탈 기반 생체 흡수 스텐트

생체 흡수 스텐트 시장 규모 : 흡수율별

  • 시장 개요
  • 저속 흡수 스텐트
  • 고속 흡수 스텐트

생체 흡수 스텐트 시장 규모 : 폴리머 기반 생체 흡수 스텐트별

  • 시장 개요
  • 폴리(젖산-글리콜산) 스텐트
  • 폴리 글리콜산스텐트
  • 폴리(L-젖산) 스텐트
  • 기타 생분해성 폴리머 스텐트

생체 흡수 스텐트 시장 규모 : 메탈 기반 생체 흡수 스텐트별

  • 시장 개요
  • 마그네슘 기반 스텐트
  • 철 기반 스텐트
  • 아연 기반 스텐트
  • 기타 메탈 기반 생체 흡수 스텐트

생체 흡수 스텐트 시장 규모 : 용도별

  • 시장 개요
  • 관상 동맥 질환
  • 말초 동맥 질환

생체 흡수 스텐트 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년대비 비교(2022-2024년)

주요 기업 개요

  • Boston Scientific Corporation(USA)
  • Arterius Limited(UK)
  • Kyoto Medical Planning Co., Ltd.(Japan)
  • Terumo Corporation(Japan)
  • Elixir Medical Corporation(USA)
  • Abbott Laboratories Inc.(USA)
  • Amaranth Medical(USA)
  • Biotronik(Germany)
  • Meril Life Sciences Pvt. Ltd.(India)
  • Reva Medical(USA)
  • Svelte Medical Systems(USA)
  • Lepu Medical Technology Co., Ltd.(China)
  • Medtronic plc(Ireland)
  • B. Braun Melsungen AG(Germany)
  • MicroPort Scientific Corporation(China)
  • Cardionovum GmbH(Germany)
  • Biotronik SE & Co. KG(Germany)
  • ICON Interventional Systems(USA)
  • Arterial Remodeling Technologies(France)
  • Elixir Medical Corporation(USA)

결론과 제안

LSH 25.04.07

Bioabsorbable Stents Market size was valued at USD 2.56 billion in 2023 and is poised to grow from USD 2.79 billion in 2024 to USD 5.51 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global bioabsorbable stents market is poised for significant growth driven by an aging population and escalating cardiovascular disease prevalence. The rise in coronary artery disease has led to an uptick in percutaneous coronary intervention (PCI) procedures, amplifying the adoption of bioabsorbable stents by both patients and healthcare providers. Technological advancements and a shift towards minimally invasive treatments further boost market expansion. Government initiatives promoting innovation and favorable regulations enhance the development of bioabsorbable stents. However, challenges such as the high cost of procedures and potential risks associated with these stents could impede growth. Overall, demographic shifts, technological progress, and supportive government measures will play crucial roles in shaping the market's future trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioabsorbable Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioabsorbable Stents Market Segments Analysis

Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioabsorbable Stents Market

The Bioabsorbable Stents market is significantly driven by advancements in design and technology, which have accelerated the treatment of coronary artery disease with biodegradable stents. These innovative stents are crafted from biodegradable polymers that safely dissolve after fulfilling their purpose, enhancing patient outcomes. Research by the U.S. FDA has highlighted the potential of these stents to mitigate late-stage complications, such as stent thrombosis. As a result, there is an increased patient acceptance and utilization, fostering wider market adoption and positioning bioabsorbable stents as a promising solution in cardiovascular care, effectively addressing a critical healthcare need for safer and more effective treatments.

Restraints in the Bioabsorbable Stents Market

The bioabsorbable stents market faces significant challenges due to concerns surrounding the long-term efficacy and safety of these devices. Healthcare providers remain skeptical, particularly following complications linked to several first-generation models, such as late stent thrombosis and restenosis, which have cast doubts on their clinical performance. These issues have negatively impacted market confidence, leading clinicians to advocate for more extensive clinical trials and the development of improved device designs. To regain trust in bioabsorbable stent technology, it is essential to establish enhanced safety profiles and provide comprehensive long-term data demonstrating their reliability and effectiveness in patient care.

Market Trends of the Bioabsorbable Stents Market

The bioabsorbable stents market is experiencing a significant trend towards the development of innovative materials aimed at enhancing clinical outcomes. Researchers are focusing on creating advanced composite materials that provide superior biocompatibility, increased mechanical strength, and optimized degradation rates. These improvements are designed to address the limitations of existing stent materials, ultimately leading to better patient outcomes and performance. This market shift highlights a commitment to enhancing the durability and long-term efficacy of bioabsorbable stents, thereby minimizing complications and bolstering the overall efficacy of cardiac interventions. As a result, growth in this segment is expected to accelerate significantly in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Bioabsorbable Stents Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Polymer-Based Bioabsorbable Stents
  • Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Absorption Rate & CAGR (2025-2032)

  • Market Overview
  • Slow-Absorption Stents
  • Fast-Absorption Stents

Global Bioabsorbable Stents Market Size by Polymer-Based Bioabsorbable Stents & CAGR (2025-2032)

  • Market Overview
  • PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents
  • PGA (Polyglycolic Acid) Stents
  • PLLA (Poly (L-Lactic Acid)) Stents
  • Other Biodegradable Polymer Stents

Global Bioabsorbable Stents Market Size by Metal-Based Bioabsorbable Stents & CAGR (2025-2032)

  • Market Overview
  • Magnesium-Based Stents
  • Iron-Based Stents
  • Zinc-Based Stents
  • Other Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Coronary Artery Diseases
  • Peripheral Artery Diseases

Global Bioabsorbable Stents Market Size & CAGR (2025-2032)

  • North America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
    • US
    • Canada
  • Europe (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arterius Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kyoto Medical Planning Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elixir Medical Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amaranth Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meril Life Sciences Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reva Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Svelte Medical Systems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardionovum GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON Interventional Systems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arterial Remodeling Technologies (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elixir Medical Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제